Periodontitis and Periodontal Bacteria in Dementia
The Role of Periodontitis and Periodontal Bacteria in Development of Dementia
1 other identifier
observational
120
1 country
1
Brief Summary
The study is designed to inquire whether the presence of periodontitis and different periodontopathogenic bacterial strains are associated with dementia diagnosis and with the degree of cognitive impairment in participants evaluated at a Memory clinic (Minnesmottagning). Specifically, by analyzing cerebrospinal fluid, the investigators intend to clarify whether the alleged mechanisms for Porphyromonas gingivalis in the aetiology of Alzheimer disease (AD) are supported in a Swedish population and whether they are specific for Porphyromonas gingivalis (as compared to other periodontopathogenic bacteria) and Alzheimer type dementia (as compared to other etiological dementia types), respectively.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 30, 2020
CompletedFirst Submitted
Initial submission to the registry
September 23, 2022
CompletedFirst Posted
Study publicly available on registry
September 28, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedApril 10, 2024
April 1, 2024
4.2 years
September 23, 2022
April 9, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Bacteriological findings in relation to neurocognitive outcome
The presence of DNA, antibodies and toxins from selected bacterial species in biobank stored cerebrospinal fluid.
2022-10-01 - 2023-12-31
Periodontitis in relation to neurocognitive outcome
Retrospectively collected clinical and radiographic periodontal status
2022-10-01 - 2023-12-31
Study Arms (1)
Memory clinic cohort
A cohort of 120 individuals that has been investigated for cognitive impairment at the Memory Clinic, Department of Geriatric Medicine, Örebro University Hospital and from which a sample of cerebrospinal fluid has been stored in biobank.
Eligibility Criteria
A cohort of 120 patients that has been investigated for cognitive impairment at the Memory Clinic, Department of Geriatric Medicine, Örebro University Hospital and from which a sample of cerebrospinal fluid has been stored in biobank.
You may qualify if:
- \- Any person that has been investigated for possible cognitive impairment at Minnesmottagningen, Department of Geriatric Medicine, Örebro University Hospital, and has a CSF sample stored in the biobank. This includes patients who received a diagnosis of dementia (major cognitive disorder) and patients not so diagnosed.
You may not qualify if:
- No CSF sample available in biobank
- Incomplete or unavailable clinical and radiological data in medical and dental records, concerning e.g. cognitive tests and AD-biomarker analyses
- Dementia with known etiological diagnosis, e.g. dementia due to alcohol use disorder or traumatic brain injury.
- Creutzfeldt-Jakob disease or other transmissible prion disease
- Non-consenting persons
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Region Örebro county
Örebro, Örebro County, 701 82, Sweden
Related Publications (1)
Dominy SS, Lynch C, Ermini F, Benedyk M, Marczyk A, Konradi A, Nguyen M, Haditsch U, Raha D, Griffin C, Holsinger LJ, Arastu-Kapur S, Kaba S, Lee A, Ryder MI, Potempa B, Mydel P, Hellvard A, Adamowicz K, Hasturk H, Walker GD, Reynolds EC, Faull RLM, Curtis MA, Dragunow M, Potempa J. Porphyromonas gingivalis in Alzheimer's disease brains: Evidence for disease causation and treatment with small-molecule inhibitors. Sci Adv. 2019 Jan 23;5(1):eaau3333. doi: 10.1126/sciadv.aau3333. eCollection 2019 Jan.
PMID: 30746447BACKGROUND
Biospecimen
Cerebrospinal fluid saved at biobank
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Susanne Bejerot, Professor
Region Örebro County
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 23, 2022
First Posted
September 28, 2022
Study Start
October 30, 2020
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
April 10, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share